Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 8.

Torres, Vicente E; Chapman, Arlene B; Devuyst, Olivier; Gansevoort, Ron T; Perrone, Ronald D; Koch, Gary; Ouyang, John; McQuade, Robert D; Blais, Jaime D; Czerwiec, Frank S; Sergeyeva, Olga (2017). Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease. New England Journal of Medicine, 377(20):1930-1942.

Grantham, Jared J; Chapman, Arlene B; Blais, Jaime; Czerwiec, Frank S; Devuyst, Olivier; Gansevoort, Ron T; Higashihara, Eiji; Krasa, Holly; Zhou, Wen; Ouyang, John; Perrone, Ronald D; Torres, Vicente E (2017). Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease. Nephrology, Dialysis, Transplantation, 32(6):969-975.

Devuyst, Olivier; Chapman, Arlene B; Gansevoort, Ron T; Higashihara, Eiji; Perrone, Ronald D; Torres, Vicente E; Blais, Jaime D; Zhou, Wen; Ouyang, John; Czerwiec, Frank S (2017). Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial. Journal of the American Society of Nephrology (JASN), 28(5):1592-1602.

Torres, Vicente E; Devuyst, Olivier; Chapman, Arlene B; Gansevoort, Ron T; Perrone, Ronald D; Ouyang, John; Blais, Jaime D; Czerwiec, Frank S; Sergeyeva, Olga (2017). Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease. American Journal of Nephrology, 45(3):257-266.

Casteleijn, Niek F; Blais, Jaime D; Chapman, Arlene B; Czerwiec, Frank S; Devuyst, Olivier; Higashihara, Eiji; Leliveld, Anna M; Ouyang, John; Perrone, Ronald D; Torres, Vicente E; Gansevoort, Ron T (2017). Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial. American Journal of Kidney Diseases, 69(2):210-219.

Gansevoort, Ron T; Meijer, Esther; Chapman, Arlene B; Czerwiec, Frank S; Devuyst, Olivier; Grantham, Jared J; Higashihara, Eiji; Krasa, Holly B; Ouyang, John; Perrone, Ronald D; Torres, Vicente E (2016). Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial. Nephrology, Dialysis, Transplantation, 31(11):1887-1894.

Chapman, Arlene B; Devuyst, Olivier; Eckardt, Kai-Uwe; Gansevoort, Ron T; Harris, Tess; Horie, Shigeo; Kasiske, Bertram L; Odland, Dwight; Pei, York; Perrone, Ronald D; Pirson, Yves; Schrier, Robert W; Torra, Roser; Torres, Vicente E; Watnick, Terry; Wheeler, David C (2015). Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: Improving global outcomes (KDIGO) controversies conference. Kidney International, 88(1):17-27.

Torres, Vicente E; Chapman, Arlene B; Devuyst, Olivier; Gansevoort, Ron T; Grantham, Jared J; Higashihara, Eiji; Perrone, Ronald D; Krasa, Holly B; Ouyang, John; Czerwiec, Frank S (2012). Tolvaptan in patients with autosomal dominant polycystic kidney disease. The New England Journal of Medicine, 367(25):2407-2418.

This list was generated on Fri May 25 08:10:07 2018 CEST.